The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Encephalitis Vaccination-Global Market Insights and Sales Trends 2025
Synopsis
Encephalitis Vaccination is an effective measure for the prevention of epidemic encephalitis. It is by yellow virus arboviruses - je virus caused an acute infectious disease of the central nervous system. Often result in death or neurological sequel. Je is a zoonotic disease spread by mosquito’s classes. People and many animals may be infection source after infection Encephalitis virus.
The global Encephalitis Vaccination market size is expected to reach US$ 1899.3 million by 2029, growing at a CAGR of 5.6% from 2023 to 2029. The market is mainly driven by the significant applications of Encephalitis Vaccination in various end use industries. The expanding demands from the Public Hospital, Private Hospital, Clinic and Other, are propelling Encephalitis Vaccination market. Encephalitis B Vaccine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Encephalitis Attenuated Live Vaccine segment is estimated at % CAGR for the next seven-year period.
The world's leading manufacturers of JE vaccines are Novartis, Sanofi, Chengdu Institute of Biological Products, Wuhan Institute of Biological Products, Lanzhou Institute of Biological Products, Beijing Taitan, Valneva, Bharat Biotech and Liaoning Chengda, etc.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Encephalitis Vaccination, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Encephalitis Vaccination market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Encephalitis Vaccination market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Encephalitis Vaccination sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Encephalitis Vaccination covered in this report include Novartis, Sanofi, Chengdu Institute of Biological Products, Wuhan Institute of Biological Products, Lanzhou Institute of Biological Products, Beijing Taitan, Valneva, Bharat Biotech and Liaoning Chengda, etc.
The global Encephalitis Vaccination market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novartis
Sanofi
Chengdu Institute of Biological Products
Wuhan Institute of Biological Products
Lanzhou Institute of Biological Products
Beijing Taitan
Valneva
Bharat Biotech
Liaoning Chengda
Global Encephalitis Vaccination market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Encephalitis Vaccination market, Segment by Type:
Encephalitis B Vaccine
Encephalitis Attenuated Live Vaccine
Global Encephalitis Vaccination market, by Application
Public Hospital
Private Hospital
Clinic
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Encephalitis Vaccination manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Encephalitis Vaccination in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Encephalitis Vaccination is an effective measure for the prevention of epidemic encephalitis. It is by yellow virus arboviruses - je virus caused an acute infectious disease of the central nervous system. Often result in death or neurological sequel. Je is a zoonotic disease spread by mosquito’s classes. People and many animals may be infection source after infection Encephalitis virus.
The global Encephalitis Vaccination market size is expected to reach US$ 1899.3 million by 2029, growing at a CAGR of 5.6% from 2023 to 2029. The market is mainly driven by the significant applications of Encephalitis Vaccination in various end use industries. The expanding demands from the Public Hospital, Private Hospital, Clinic and Other, are propelling Encephalitis Vaccination market. Encephalitis B Vaccine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Encephalitis Attenuated Live Vaccine segment is estimated at % CAGR for the next seven-year period.
The world's leading manufacturers of JE vaccines are Novartis, Sanofi, Chengdu Institute of Biological Products, Wuhan Institute of Biological Products, Lanzhou Institute of Biological Products, Beijing Taitan, Valneva, Bharat Biotech and Liaoning Chengda, etc.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Encephalitis Vaccination, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Encephalitis Vaccination market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Encephalitis Vaccination market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Encephalitis Vaccination sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Encephalitis Vaccination covered in this report include Novartis, Sanofi, Chengdu Institute of Biological Products, Wuhan Institute of Biological Products, Lanzhou Institute of Biological Products, Beijing Taitan, Valneva, Bharat Biotech and Liaoning Chengda, etc.
The global Encephalitis Vaccination market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novartis
Sanofi
Chengdu Institute of Biological Products
Wuhan Institute of Biological Products
Lanzhou Institute of Biological Products
Beijing Taitan
Valneva
Bharat Biotech
Liaoning Chengda
Global Encephalitis Vaccination market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Encephalitis Vaccination market, Segment by Type:
Encephalitis B Vaccine
Encephalitis Attenuated Live Vaccine
Global Encephalitis Vaccination market, by Application
Public Hospital
Private Hospital
Clinic
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Encephalitis Vaccination manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Encephalitis Vaccination in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Encephalitis Vaccination Market Overview
1.1 Encephalitis Vaccination Product Overview
1.2 Encephalitis Vaccination Market Segment by Type
1.2.1 Encephalitis B Vaccine
1.2.2 Encephalitis Attenuated Live Vaccine
1.3 Global Encephalitis Vaccination Market Size by Type
1.3.1 Global Encephalitis Vaccination Market Size Overview by Type (2018-2029)
1.3.2 Global Encephalitis Vaccination Historic Market Size Review by Type (2018-2023)
1.3.3 Global Encephalitis Vaccination Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Encephalitis Vaccination Sales Breakdown by Type (2018-2023)
1.4.2 Europe Encephalitis Vaccination Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Encephalitis Vaccination Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Encephalitis Vaccination Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Encephalitis Vaccination Sales Breakdown by Type (2018-2023)
2 Global Encephalitis Vaccination Market Competition by Company
2.1 Global Top Players by Encephalitis Vaccination Sales (2018-2023)
2.2 Global Top Players by Encephalitis Vaccination Revenue (2018-2023)
2.3 Global Top Players by Encephalitis Vaccination Price (2018-2023)
2.4 Global Top Manufacturers Encephalitis Vaccination Manufacturing Base Distribution, Sales Area, Product Type
2.5 Encephalitis Vaccination Market Competitive Situation and Trends
2.5.1 Encephalitis Vaccination Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Encephalitis Vaccination Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Encephalitis Vaccination as of 2022)
2.7 Date of Key Manufacturers Enter into Encephalitis Vaccination Market
2.8 Key Manufacturers Encephalitis Vaccination Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Encephalitis Vaccination Status and Outlook by Region
3.1 Global Encephalitis Vaccination Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Encephalitis Vaccination Historic Market Size by Region
3.2.1 Global Encephalitis Vaccination Sales in Volume by Region (2018-2023)
3.2.2 Global Encephalitis Vaccination Sales in Value by Region (2018-2023)
3.2.3 Global Encephalitis Vaccination Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Encephalitis Vaccination Forecasted Market Size by Region
3.3.1 Global Encephalitis Vaccination Sales in Volume by Region (2024-2029)
3.3.2 Global Encephalitis Vaccination Sales in Value by Region (2024-2029)
3.3.3 Global Encephalitis Vaccination Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Encephalitis Vaccination by Application
4.1 Encephalitis Vaccination Market Segment by Application
4.1.1 Public Hospital
4.1.2 Private Hospital
4.1.3 Clinic
4.1.4 Other
4.2 Global Encephalitis Vaccination Market Size by Application
4.2.1 Global Encephalitis Vaccination Market Size Overview by Application (2018-2029)
4.2.2 Global Encephalitis Vaccination Historic Market Size Review by Application (2018-2023)
4.2.3 Global Encephalitis Vaccination Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Encephalitis Vaccination Sales Breakdown by Application (2018-2023)
4.3.2 Europe Encephalitis Vaccination Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Encephalitis Vaccination Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Encephalitis Vaccination Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Encephalitis Vaccination Sales Breakdown by Application (2018-2023)
5 North America Encephalitis Vaccination by Country
5.1 North America Encephalitis Vaccination Historic Market Size by Country
5.1.1 North America Encephalitis Vaccination Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Encephalitis Vaccination Sales in Volume by Country (2018-2023)
5.1.3 North America Encephalitis Vaccination Sales in Value by Country (2018-2023)
5.2 North America Encephalitis Vaccination Forecasted Market Size by Country
5.2.1 North America Encephalitis Vaccination Sales in Volume by Country (2024-2029)
5.2.2 North America Encephalitis Vaccination Sales in Value by Country (2024-2029)
6 Europe Encephalitis Vaccination by Country
6.1 Europe Encephalitis Vaccination Historic Market Size by Country
6.1.1 Europe Encephalitis Vaccination Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Encephalitis Vaccination Sales in Volume by Country (2018-2023)
6.1.3 Europe Encephalitis Vaccination Sales in Value by Country (2018-2023)
6.2 Europe Encephalitis Vaccination Forecasted Market Size by Country
6.2.1 Europe Encephalitis Vaccination Sales in Volume by Country (2024-2029)
6.2.2 Europe Encephalitis Vaccination Sales in Value by Country (2024-2029)
7 Asia-Pacific Encephalitis Vaccination by Region
7.1 Asia-Pacific Encephalitis Vaccination Historic Market Size by Region
7.1.1 Asia-Pacific Encephalitis Vaccination Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Encephalitis Vaccination Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Encephalitis Vaccination Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Encephalitis Vaccination Forecasted Market Size by Region
7.2.1 Asia-Pacific Encephalitis Vaccination Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Encephalitis Vaccination Sales in Value by Region (2024-2029)
8 Latin America Encephalitis Vaccination by Country
8.1 Latin America Encephalitis Vaccination Historic Market Size by Country
8.1.1 Latin America Encephalitis Vaccination Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Encephalitis Vaccination Sales in Volume by Country (2018-2023)
8.1.3 Latin America Encephalitis Vaccination Sales in Value by Country (2018-2023)
8.2 Latin America Encephalitis Vaccination Forecasted Market Size by Country
8.2.1 Latin America Encephalitis Vaccination Sales in Volume by Country (2024-2029)
8.2.2 Latin America Encephalitis Vaccination Sales in Value by Country (2024-2029)
9 Middle East and Africa Encephalitis Vaccination by Country
9.1 Middle East and Africa Encephalitis Vaccination Historic Market Size by Country
9.1.1 Middle East and Africa Encephalitis Vaccination Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Encephalitis Vaccination Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Encephalitis Vaccination Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Encephalitis Vaccination Forecasted Market Size by Country
9.2.1 Middle East and Africa Encephalitis Vaccination Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Encephalitis Vaccination Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Novartis
10.1.1 Novartis Company Information
10.1.2 Novartis Introduction and Business Overview
10.1.3 Novartis Encephalitis Vaccination Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Novartis Encephalitis Vaccination Products Offered
10.1.5 Novartis Recent Development
10.2 Sanofi
10.2.1 Sanofi Company Information
10.2.2 Sanofi Introduction and Business Overview
10.2.3 Sanofi Encephalitis Vaccination Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Sanofi Encephalitis Vaccination Products Offered
10.2.5 Sanofi Recent Development
10.3 Chengdu Institute of Biological Products
10.3.1 Chengdu Institute of Biological Products Company Information
10.3.2 Chengdu Institute of Biological Products Introduction and Business Overview
10.3.3 Chengdu Institute of Biological Products Encephalitis Vaccination Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Chengdu Institute of Biological Products Encephalitis Vaccination Products Offered
10.3.5 Chengdu Institute of Biological Products Recent Development
10.4 Wuhan Institute of Biological Products
10.4.1 Wuhan Institute of Biological Products Company Information
10.4.2 Wuhan Institute of Biological Products Introduction and Business Overview
10.4.3 Wuhan Institute of Biological Products Encephalitis Vaccination Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Wuhan Institute of Biological Products Encephalitis Vaccination Products Offered
10.4.5 Wuhan Institute of Biological Products Recent Development
10.5 Lanzhou Institute of Biological Products
10.5.1 Lanzhou Institute of Biological Products Company Information
10.5.2 Lanzhou Institute of Biological Products Introduction and Business Overview
10.5.3 Lanzhou Institute of Biological Products Encephalitis Vaccination Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Lanzhou Institute of Biological Products Encephalitis Vaccination Products Offered
10.5.5 Lanzhou Institute of Biological Products Recent Development
10.6 Beijing Taitan
10.6.1 Beijing Taitan Company Information
10.6.2 Beijing Taitan Introduction and Business Overview
10.6.3 Beijing Taitan Encephalitis Vaccination Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Beijing Taitan Encephalitis Vaccination Products Offered
10.6.5 Beijing Taitan Recent Development
10.7 Valneva
10.7.1 Valneva Company Information
10.7.2 Valneva Introduction and Business Overview
10.7.3 Valneva Encephalitis Vaccination Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Valneva Encephalitis Vaccination Products Offered
10.7.5 Valneva Recent Development
10.8 Bharat Biotech
10.8.1 Bharat Biotech Company Information
10.8.2 Bharat Biotech Introduction and Business Overview
10.8.3 Bharat Biotech Encephalitis Vaccination Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Bharat Biotech Encephalitis Vaccination Products Offered
10.8.5 Bharat Biotech Recent Development
10.9 Liaoning Chengda
10.9.1 Liaoning Chengda Company Information
10.9.2 Liaoning Chengda Introduction and Business Overview
10.9.3 Liaoning Chengda Encephalitis Vaccination Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Liaoning Chengda Encephalitis Vaccination Products Offered
10.9.5 Liaoning Chengda Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Encephalitis Vaccination Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Encephalitis Vaccination Industrial Chain Analysis
11.4 Encephalitis Vaccination Market Dynamics
11.4.1 Encephalitis Vaccination Industry Trends
11.4.2 Encephalitis Vaccination Market Drivers
11.4.3 Encephalitis Vaccination Market Challenges
11.4.4 Encephalitis Vaccination Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Encephalitis Vaccination Distributors
12.3 Encephalitis Vaccination Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
